This prospective follow-up study of a randomized clinical trial evaluates whether antenatal corticosteroids administered to birthing parents at risk of
Intranasal oxytocin appears to improve social functioning and quality of life in individuals with autism spectrum disorder, results of a randomized control trial show.
Supplementation during pregnancy also reduced communication warning behaviors in children who developed autism compared to the children of women who did not take supplements.